Stay updated on ECT-Pembrolizumab for Unresectable Melanoma Clinical Trial

Sign up to get notified when there's something new on the ECT-Pembrolizumab for Unresectable Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ECT-Pembrolizumab for Unresectable Melanoma Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    - Updated page revision from v3.0.0 to v3.0.2. No other substantive content changes detected.
    Difference
    0.1%
    Check dated 2025-09-13T17:36:57.000Z thumbnail image
  2. Check
    15 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of new therapeutic techniques and the removal of specific disease-related resources and terms.
    Difference
    2%
    Check dated 2025-08-30T11:39:20.000Z thumbnail image
  3. Check
    22 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.1%
    Check dated 2025-08-16T04:29:25.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.10 to v2.16.11.
    Difference
    0.1%
    Check dated 2025-08-08T23:49:41.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    1.0%
    Check dated 2025-08-01T19:19:16.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new version, changing from Revision v2.16.6 to v2.16.8, indicating a potential improvement or update in the content or functionality.
    Difference
    0.2%
    Check dated 2025-07-25T14:32:48.000Z thumbnail image

Stay in the know with updates to ECT-Pembrolizumab for Unresectable Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ECT-Pembrolizumab for Unresectable Melanoma Clinical Trial page.